EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, DocMorris AG's enterprise value is CHF984.9 Mil.
DocMorris AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF969.5 Mil. Therefore, DocMorris AG's EV-to-Revenue for today is 1.02.
The historical rank and industry rank for DocMorris AG's EV-to-Revenue or its related term are showing as below:
XSWX:DOCM'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.28 Med: 0.82 Max: 3.28
Current: 1.02
During the past 13 years, the highest EV-to-Revenue of DocMorris AG was 3.28. The lowest was 0.28. And the median was 0.82.
XSWX:DOCM's EV-to-Revenue is ranked better than 69.53% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 1.85
vs XSWX:DOCM: 1.02
As of today (2024-05-26), DocMorris AG's stock price is CHF64.50.
DocMorris AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF83.05. Therefore, DocMorris AG's PS Ratio for today is 0.78.
DocMorris AG EV-to-Revenue Historical Data
The historical data trend for DocMorris AG's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of DocMorris AG's EV-to-Revenue
For the Pharmaceutical Retailers subindustry, DocMorris AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where DocMorris AG's EV-to-Revenue falls into.
DocMorris AG's current Enterprise Value is CHF984.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocMorris AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF969.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) EV-to-Revenue Explanation
DocMorris AG's share price for today is CHF64.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was CHF83.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of DocMorris AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:DOCM has been successfully added to your 